C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2004
12/23/2004	WO2004076684A3 Compositions and methods for the detection of mammalian muscle troponin i
12/23/2004	WO2004074310A8 Mycobacterial diagnostics
12/23/2004	WO2004072269A3 Bex4 nucleic acids, polypeptides, and method of using
12/23/2004	WO2004072263A3 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
12/23/2004	WO2004067706A3 Production of multimeric proteins
12/23/2004	WO2004055169A3 Cytochrome c acetylation
12/23/2004	WO2004045499A3 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
12/23/2004	WO2004042043A3 Crystal structures of bacterial ribulose-phosphate 3-epimerases
12/23/2004	WO2004035753A3 Lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosis
12/23/2004	WO2004035612B1 Composition, method and use of bi-functional biomaterials
12/23/2004	WO2004024182A3 Method for isolating hepatitis c virus peptides
12/23/2004	WO2004022004A3 Modified glp-1 receptor agonists and their pharmacological methods of use
12/23/2004	WO2004013294A3 Method of producing non-recombinant bmp-2 and use thereof
12/23/2004	WO2004007685A3 Methods of modifying behavior of cd9-expressing cells
12/23/2004	WO2003106692A3 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/23/2004	WO2003106634A3 Vectors for expression of hml-2 polypeptides
12/23/2004	WO2003106491A3 Cell penetrating peptides
12/23/2004	WO2003104427A3 Methods and compositions for detecting cancers
12/23/2004	WO2003101497A8 Knockout mice and their use
12/23/2004	WO2003083436A3 Fibrinogen binding moieties
12/23/2004	WO2003076584A3 Novel proteins and nucleic acids encoding same
12/23/2004	WO2003076569A3 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
12/23/2004	WO2003072713A3 Use of bcma as an immunoregulatory agent
12/23/2004	WO2003063679A8 Hepatitis e virus clones and methods of their use
12/23/2004	WO2003052075A3 Enzymes
12/23/2004	WO2003050236A3 Human genes and gene expression products isolated from human prostate
12/23/2004	WO2002077013A3 Human secreted proteins
12/23/2004	US20040261148 Monoclonal antibodies with effector function; signal sequences
12/23/2004	US20040261142 Mutated Src oncogene composition and methods
12/23/2004	US20040261141 Animal model for therapy of diseases of the eye
12/23/2004	US20040261140 For analyzing inflammatory response associated with cystic fibrosis; screening compounds which inhibit or prevent the recruitment of neutrophils
12/23/2004	US20040261139 Androgen receptor knock-out transgenic animals
12/23/2004	US20040260079 Cardiac-cell specific enhancer elements and uses thereof
12/23/2004	US20040260078 Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy
12/23/2004	US20040260071 Benzophene-linked crf and crf-like peptides for covalent labeling of corticotropin-releasing factor crf binding protein
12/23/2004	US20040260070 Method and apparatus for detecting conception in animals
12/23/2004	US20040260066 Method for purifying mixtures of immunoglobulin & albumin
12/23/2004	US20040260065 Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo
12/23/2004	US20040260064 Monoclonal antibodies or fragments thereof which bind macrophage stimulating protein (MSP) analog comprising unpaired cysteine residue substituted with another amino acid, and which does not bind to wild-type MSP; for treatment of gastrointestinal and hematopoietic disorders
12/23/2004	US20040260063 Chimeric peptide: antagonist, endogeneous ligand binding to protein; therapy for metabolism disorders; obesity
12/23/2004	US20040260062 Stress-responsive activator of p300 (strap) protein
12/23/2004	US20040260058 Point mutations, deletions; quantitative/qualitative analysis; immunoassay; blot analysis; drug screening
12/23/2004	US20040259839 Foods, printing dyes, oil well drilling fluids, ceramic glaze, drugs
12/23/2004	US20040259825 Gene expression vectors; intensifier dor sequence determiantion; induce immunology response; viricides
12/23/2004	US20040259807 Monocyte locomotion inhibitory factor
12/23/2004	US20040259800 Apoptosis of rectum and prostate cancer
12/23/2004	US20040259797 peptide mixture; induce immunology response; gag protein; vaccines
12/23/2004	US20040259796 Using a peptide
12/23/2004	US20040259795 Reducing sepsis; binding polypeptide to monoclonal antibody ; intensify gene expression; wound healing agents
12/23/2004	US20040259794 MuO-conopeptides and their use as local anesthetics
12/23/2004	US20040259791 Methods of inducing apoptosis in hyperproliferative cells
12/23/2004	US20040259789 Stimulant gene expression of peptide
12/23/2004	US20040259787 C1q and collectin receptor
12/23/2004	US20040259785 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
12/23/2004	US20040259783 Pharmaceutical compositions of marine sponge microciona prolifera
12/23/2004	US20040259782 Structural formulas based on the repetitive motifs of salivary proline rich proteins mucin and collagen designed to modulate cell and tissue growth division and differentiation
12/23/2004	US20040259781 Drug screening ; polypeptide interfers with binding of fibronectin to; anticancer agents; antihistamines, antiarthritic agents, autoimmune disease, wound healing agents
12/23/2004	US20040259779 Novel neurotrophic factors
12/23/2004	US20040259778 Utilization of histamine receptor h3 gene participating in body weight or food intake control
12/23/2004	US20040259777 Method of treating metabolic disorders using neuronatin polypeptides
12/23/2004	US20040259776 Screening for apoptosis
12/23/2004	US20040259775 Receptor ligand; for opiods; analgesics, anxiolytic agents, drug abuse, cognition activators
12/23/2004	US20040259774 Nucleotide sequences; binding to antibodies
12/23/2004	US20040259773 Viricide peptide; nucleic acids encoding cyclic peptide
12/23/2004	US20040259769 Hemoglobulin for oxygen delivery; cardiovascular disorders; gastrointestinal disorders
12/23/2004	US20040259768 Deactivable compound produced by target cell; diagnosis, therapy disease
12/23/2004	US20040259767 Antiproliferative agents; therapy for human progessive leukoencephalophy ; suppression of dna viruses; anticancer agents
12/23/2004	US20040259257 Nucleic acid having promoter activity and transformed plant containing the same
12/23/2004	US20040259255 Helper virus-free AAV production
12/23/2004	US20040259251 oncosuppressive gene involved in the apoptotic process and is regulated by p53 ad p73; nucleic acids and polypeptides for use in drug screening and as antitumor agents
12/23/2004	US20040259250 Methods and compositions for modifying a receptor tyrosine kinase protein tyrosine kinase signal to an apoptotic signal in a cell
12/23/2004	US20040259225 Virulent systemic feline calicivirus
12/23/2004	US20040259224 prevent or to treat Dengue infection; inducing an immune response to the four serotypes of dengue virus using a vaccine comprising four chimera comprising the capsid and non-structural proteins of Yellow Fever virus and the pre-membrane and envelope proteins of Dengue-1,-2,-3, and -4 virus types
12/23/2004	US20040259223 Process for the purification of epi-hne proteins
12/23/2004	US20040259221 separation of DNA binding nuclear proteins from a cellular sample before proteomic analysis using a volatile buffer such as ammonium bicarbonate such that no dialysis step is needed between extraction and separation steps
12/23/2004	US20040259220 CLK protein kinases and related products and methods
12/23/2004	US20040259211 Rapid induction of Alzheimer's amyloid plaque formation by sulfated glycosaminoglycans
12/23/2004	US20040259209 Immunoglobulins; Chinese hamster ovary cell lines; site-directed mutagenesis; improved pharmacokinetics and pharmacodynamics; side effect reduction
12/23/2004	US20040259208 Such as mounse transthyretin (mTTR) promoter (antibody); recombinant lentiviruses and transfer vectors for transgene delivery and gene therapy; blood coagulation factor IX; antihemopohilic factor
12/23/2004	US20040259205 Controlling sialic acid present on oligosaccharide side chain of glycoprotein produced by mammalian cell culture via adding sodium butyrate and maintaining osmolality; for production of tumor necrosis factor immunolglobulin for treatment of inflammatory or immune related disorders
12/23/2004	US20040259204 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/23/2004	US20040259202 Novel angiogenesis inhibitor
12/23/2004	US20040259201 Recombinant surfactant protein D compositions and methods of use thereof
12/23/2004	US20040259196 T cell receptor variants expressed in mesenchymal cells and uses thereof
12/23/2004	US20040259195 Anti-cellular proliferative disorder polypeptide
12/23/2004	US20040259194 Cell line and uses thereof
12/23/2004	US20040259193 using a polypeptide having JAB subunit or the JAM domain that confers isopeptidase activity to deconjugate a modifier protein from a target protein; e.g. de-ubiquitination; use in drug screening
12/23/2004	US20040259192 into two fragments, using the human matrix metalloproteinase MMP-3; administering 3-(3-mercaptopropyl)-1-methyl-(1H,3H)quinazoline-2,4-dione and/or 3-(2'-mercaptoethylamino)-2H-1,2,4-benzothiadiazine-1,1-dioxide to treat tumors or diabetic retinopathy; also wound healing, cardiac infarction treatment
12/23/2004	US20040259175 Human prostate cancer candidate protein 1
12/23/2004	US20040259171 P2Y4 antibody and methods of use
12/23/2004	US20040259167 Isolated osteocalcin fragments
12/23/2004	US20040259165 Non-oligomerizing tandem fluorescent proteins
12/23/2004	US20040259164 Capture and release based isotope tagged peptides and methods for using the same
12/23/2004	US20040259160 drug screening for agents that induce glucose-stimulated insulin production to treat type-2 diabetes; "beta-TRP" polypeptide refers to a calcium channel; transforming islet cells with expression cassettes encoding beta-TRP into diabetic islet cells to improve glucose-stimulated insulin production
12/23/2004	US20040259157 multiple coagulation factor deficiency 2 protein (MCFD2); assays for the detection of MCFD2 and polymorphisms and mutations associated with disease states; diagnosis of factor V and factor VIII deficiency
12/23/2004	US20040259155 e.g., a catalytic motif such as a serine protease triad or a binding motif such as a metal binding motif, into a polypeptide such as a polypeptide that binds to a ligand or substrate, e.g., an antibody or cytokine receptor; causing proteolysis of the target; biodrugs
12/23/2004	US20040259151 containing a prosthetic group and/or subunits on the surface of a host cell using the transporter domain of an autotransporter; use of host cell for toxicity monitoring, drug screening or synthesis of organic substances such as enzyme substrates, drugs, hormones, intermediates thereto
12/23/2004	US20040259145 Compositions and methods for the modification of gene expression
12/23/2004	US20040259139 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
12/23/2004	US20040259132 PNA probe is complementary to a target sequence of 23S rRNA or rDNA; detecting Pseudomonas in a sample of interest; kits

1 ... 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 ... 2916